FDA Person
Office of Prescription Drug PromotionTwyla Mosey
View detailed information about Twyla Mosey, including compliance records, violations, and related data.
Person Profile
FDA investigator, Office of Prescription Drug Promotion.
Documents (3)
- WARNING LETTER · Sage Pharmaceuticals, Inc. · April 24, 2025
- WARNING LETTER · IPR Pharmaceuticals, Inc. · June 10, 2025
- WARNING LETTER · AstraZeneca Pharmaceuticals LP · August 15, 2023
Related Office
Person Information
Name
Twyla Mosey
Title
Director
Role
Regulatory Personnel
ID: 1be901d0-b29b-4de7-85fd-a0f2e203e669
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.